BioSpace News Archive

Sartorius recently recognized startup company MyoGene Bio at the QB3 Pitch Summit, a competition showcasing promising new life science companies. This award provides the company with a $25,000 voucher that they can use for the purchase of any Sartorius products and services to support their development of a gene therapy for Duchenne muscular dystrophy (DMD). MyoGene Bio’s MyoDys 45-55 gene editing therapy uses CRISPR

Unique polymers in DermSafe retain moisture to help protect against excessive dry hands & contact dermatitis Chlorhexidine Gluconate (CHG) used by doctors and dentists around the globe to kill germs Recipient of the Canadian Dermatology Review Panel ( DRP ) Seal of Approval

Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, today announced it has received a grant from the Bill & Melinda Gates Foundation in the amount of $5 million to continue to advance INSPECTRTM, its instrument-free, synthetic biology-based molecular diagnostics platform.

Spinal Elements, a spine technology company, today announced the acquisition of the assets of Benvenue Medical, Inc., a developer of MIS lumbar fusion systems

Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, today announced that it approved equity awards for 46 new employees with a grant date of December 15, 2020 pursuant to Myovant’s 2020 Inducement Plan.

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Senhance® Surgical System has received its registration certificate by Roszdravnadzor, the Russian medical device regulatory agency allowing for its sale and utilization throughout the Russian Federation.

Two out of three people with lupus are willing to take a COVID-19 vaccine if it is free and determined safe by scientists according to results of a survey conducted by the Lupus Research Alliance.

Simulations Plus, Inc., a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, announced that it has published its inaugural Environmental, Social, and Governance report.

Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that two patients who have undergone heart bypass surgeries utilizing HJLIs CoreoGraft have reached the 30-day milestone and are reported to have good cardiac function.

CereHealth Corp., a data analytics technology company that provides Medical Analytics as a Service announced today the addition of James Chomas, Ph.D. and Ty Vachon, M.D. to their Scientific and Medical Advisory Board.